The HHS renewed the national public health emergency for the monkeypox outbreak in the United States; more demand for amoxicillin has led to a nationwide shortage as respiratory illnesses continue to spread; a drug already approved for weight loss in adults has demonstrated promise in teenagers aged 12 to 17 years.
HHS announced that it is renewing the national public health emergency for the monkeypox outbreak, according to The Hill. The continued consequences of the outbreak in multiple states were cited as the reason to prolong the declared health emergency, as well as the need to maintain the flow of data and allow studies on vaccine effectiveness to continue. This news comes as new studies have found that monkeypox can spread prior to symptoms appearing, according to Reuters, which challenges the previously held belief that monkeypox is primarily spread by people already sick.
A shortage of amioxicillin has been caused by an increase in respiratory illnesses in children throughout the country, according to The Washington Post. Pharmacists say that amoxicillin in some form is still available, but parents may have to visit multiple pharmacies or accept a different strength or form than originally prescribed due to the shortage. The shortage is mostly affecting supplies of the liquid version and some chewable tablet forms. The shortage may last only as long as respiratory syncytial virus (RSV) season does, as the shortage is in large part due to the influx of children admitted to the hospital with a diagnosis of RSV.
A clinical trial found that teenagers with obesity were able to lose weight when using semaglutide (Wegovy), which reduces appetite, according to NBC News. The study found that more than 40% of the participants, aged 12 to 17 years, who received the drug and lifestyle counseling saw a reduction in their body mass index by 20% or more. Semaglutide has previously been found to benefit adults who have type 2 diabetes and has been proven to help weight loss in adults, with the FDA approving the drug for weight loss in 2021. Long-term effectiveness of the drug has yet to be determined.
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
The Breakdown: Breast Cancer Research Awareness Day
August 19th 2025Breast cancer is the second most common cancer among women and the second leading cause of cancer-related deaths among women in the US. In light of Breast Cancer Research Awareness Day, The American Journal of Managed Care® breaks down the most recent advancements in breast cancer prevention, screening, and therapies.
Listen
Interhospital Transfers Occur Less Frequently for Uninsured Patients
August 27th 2025Patients with acute respiratory failure who’ve been placed on a mechanical ventilator are less likely to be transferred to high-volume centers if they are uninsured, thus increasing their odds of mortality.
Read More